PT  - JOURNAL ARTICLE
AU  - Bhagavathula, Akshaya Srikanth
AU  - Rahmani, Jamal
AU  - Aldhaleei, Wafa Ali
AU  - Kumar, Pavan
AU  - Rovetta, Alessandro
TI  - Global, Regional and National Incidence and Case-fatality rate of Novel Coronavirus (COVID-19) across 154 countries and territories: A systematic assessment of cases reported from January to March 16, 2020
AID  - 10.1101/2020.03.26.20044743
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.03.26.20044743
4099  - http://medrxiv.org/content/early/2020/03/30/2020.03.26.20044743.short
4100  - http://medrxiv.org/content/early/2020/03/30/2020.03.26.20044743.full
AB  - Background The surge of 2019 novel coronavirus disease (COVID-19) outbreak was turned to a pandemic with hundreds and thousands of cases reported globally. The number of cases dramatically increased from early March 2020.Aim We assessed the cumulative change in the incidence and case-fatality rate of COVID-19 at global, regional, and national levels from January – March 16, 2020, across 154 affected countries and territories globally.Methods We collected data of COVID-19 cases using the GitHub repository, that provided support to real-time surveillance information developed by the Center for Systems Science and Engineering (CSSE), Johns Hopkins University, USA. Information such as confirmed COVID-19 cases, deaths, and recoveries reported across all affected countries was collected from January 22 to March 16, 2020. We estimated the change in the incidence, case-fatality rate, and recovery rate from January 22 to February 29 and March 1 to March 16, 2020.Results From January 22 to March 16, 2020, globally, COVID-19 incident cases increased by 276.2%, and Europe recorded 65,281 new cases from March 1 to 16, 2020. Overall, the case-fatality rate was 3.92%, and with a high fatality of COVID-19 cases in Italy (7.7%), Iran (5.7%), China (4.2%) and United Kingdom (3.6%). The estimated percentage change in the COVID-19 cases from March 1 to 16, 2020, was highest in Belgium (105.8/100,000 population), followed by Qatar (439/100,000 population) and Portugal (331/100,000 population). However, the overall recovery rate of COVID-19 was found to 43%, China (35.5%) has the highest recovery rate, while the United States of America recorded 0.3%.Conclusion Overall, all the COVID-19 affected countries showed an upward trend globally, with a little change in the incidence rate of -0.20 from January to Mid-March. The case-fatality rate was found to be 3.92%, and the recovery rate was observed to be less than half (43%) among COVID-19 patients. Italy, Iran, and Spain carried the most substantial new cases of COVID-19 from March 1 to 16, 2020.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is readily available upon contacting the corresponding author.